This paper aims to analyze the therapeutic effect of methyldopa combined with rabelol treatment in patients with pregnancy pregnancy induced hypertension. A total of 70 patients with gestational hypertension diagnosed in our hospital during the period from March 2021 to March 2023 were selected as the research objects. According to different treatment methods, 35 patients treated with magnesium sulfate were included in the reference group, while 35 patients treated with methyldopa combined with rabelol were included in the observation group. Blood pressure and urinary protein levels before and after treatment were compared, hemodynamic indicators,serum indicators and the pregnancy outcomes were compared between the two groups of patients. Result: Before treatment, there was no significant difference in various indicators between the two groups, with no statistical significance (P>0.05). After treatment, the blood pressure, urinary protein level, hemodynamic index, and serum indicators of the observation group were better than those of the reference group, with significant statistical significance (P<0.05). In terms of comparison of adverse pregnancy outcomes, the incidence rates of intrauterine distress, neonatal asphyxia, premature birth, etc. in the observation group were lower than those in the reference group, and the difference was statistically significant (P<0.05). The treatment effect of methyldopa combined with rabelol treatment in patients with gestational hypertension is significant positive, which can control blood pressure and urine protein to reach the ideal range, effectively improve hemodynamic indicators, protect patient vascular endothelial function, and reduce the probability of adverse pregnancy outcomes caused by hypertension. It has great medical significance for ensuring maternal safety and safe production.

Lingyan Zhang, Xiaoshan Zhang. The Effect of Methyldopa Combined with Rabelol Treatment on Patients with Pregnancy Induced Hypertension. Frontiers in Medical Science Research (2023) Vol. 5, Issue 12: 57-62. https://doi.org/10.25236/FMSR.2023.051207.

[1] Fei Han, Ning Chen. Clinical efficacy and safety observation of rabelol combined with methyldopa in the treatment of 42 cases of gestational hypertension [J]. Drug Evaluation, 2022-19 (16): 1004-1007

[2] Junrong Jia. Clinical study on the combination of rabelol and methyldopa in patients with gestational hypertension and its impact on biochemical and hemodynamic indicators in pregnant women [J]. Journal of Applied Gynecology Endocrinology, 2021, 8 (14): 89-91

[3] Xiaoli Guo. The effect of methyldopa combined with rabelol on hemodynamics and pregnancy outcomes in patients with preeclampsia [J]. Harbin Medical Journal, 2022,42 (05): 19-21

[4] Dan Meng, Junxia Li, Xuebin Cao, et al. Progress in the application of antihypertensive drugs in the treatment of gestational hypertension [J]. Chinese Journal of Evidence-based Cardiovascular Medicine, 2021,13 (02): 254-256

[5] Junping Liu. The effect of methyldopa combined with rabolol in the treatment of preeclampsia in pregnant women [J]. China Minkang Medical Journal, 2021,33 (05): 48-50

[6] Lili Fang, Haitao Wang, Xiuhong Fu. Observation of the therapeutic effect of methyldopa combined with rabolol in the treatment of gestational hypertension [J]. Clinical Medical Engineering, 2020, 27 (05): 633-634

[7] Weizhen Li, Houyun Chen. Clinical efficacy of methyldopa combined with rabolol in the treatment of severe preeclampsia in pregnant women [J]. Chinese and Foreign Medical Research, 2020,18 (31): 134-137

[8] Xuexia Chen. Clinical efficacy and adverse reactions analysis of methyldopa+rabelol in the treatment of gestational hypertension [J]. Northern Pharmacology, 2020,17 (11): 181-182

[9] Xingwei Zhang. The effect of magnesium sulfate, methyldopa, and rabelol triple therapy on patients with gestational hypertension [J]. China Minkang Medical Journal, 2020,32 (11): 16-18

[10] Jinhua Li, Zhenhua Zhao. Clinical observation on the treatment of gestational hypertension with combination of methyldopa and rabolol [J]. Journal of Community Medicine, 2020,18 (13): 930-933

[11] Juan Dou, Qing Zhao. The efficacy of methyldopa combined with rabelol in the treatment of gestational hypertension and its impact on vascular endothelial function and blood PAPP-A levels [J]. Medical Theory and Practice, 2019,32 (02): 240-242

[12] Shuwen Lin, Weiquan Wu. Clinical observation and evaluation of the combination of methyldopa and rabolol in the treatment of gestational hypertension [J]. Chinese Medical Science, 2019,9 (20): 41-43

[13] Jianmin Hao, Tao Lu, Juan Qiu, et al. The effect of combined use of rabolol and methyldopa on biochemical and hemodynamic indicators in pregnant women with gestational hypertension [J]. Drug Evaluation, 2019,16 (16): 78-80

[14] Xiulan Niu. The application of methyldopa combined with rabolol in the clinical treatment of patients with gestational hypertension [J]. World Latest Medical Information Digest, 2019,19 (92): 230

[15] Guoting Liu. Clinical efficacy and safety of methyldopa combined with rabolol in the treatment of gestational hypertension [J]. Chinese Prescription Medicine, 2019,17 (07): 68-69

[16] Yinfeng Lv, Aihong Wei, Jia Lu, et al. The effect of rabelol combined with methyldopa on hemodynamic indicators and maternal and fetal pregnancy outcomes in patients with gestational hypertension [J]. Journal of Preventive Medicine of the People’s Liberation Army, 2018,36 (11): 1425-1427+1431